Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Empagliflozin improved systolic blood pressure, endothelial dysfunction and heart remodeling in the metabolic syndrome ZSF1 rat.
Park SH, Farooq MA, Gaertner S, Bruckert C, Qureshi AW, Lee HH, Benrahla D, Pollet B, Stephan D, Ohlmann P, Lessinger JM, Mayoux E, Auger C, Morel O, Schini-Kerth VB. Park SH, et al. Among authors: lessinger jm. Cardiovasc Diabetol. 2020 Feb 18;19(1):19. doi: 10.1186/s12933-020-00997-7. Cardiovasc Diabetol. 2020. PMID: 32070346 Free PMC article.
The association between macrovascular complications and intensive care admission, invasive mechanical ventilation, and mortality in people with diabetes hospitalized for coronavirus disease-2019 (COVID-19).
Llauradó G, Vlacho B, Wargny M, Ruan Y, Franch-Nadal J, Domingo P, Gourdy P, Saulnier PJ, Hadjadj S, Wild SH, Rea R, Cariou B, Khunti K, Mauricio D; CORONADO, the ABCD COVID-19 diabetes national audit, HM Hospitales investigators and the Hospital del Mar - Hospital de la Santa Creu i Sant Pau Diabetes Research Group. Llauradó G, et al. Cardiovasc Diabetol. 2022 Oct 19;21(1):216. doi: 10.1186/s12933-022-01657-8. Cardiovasc Diabetol. 2022. PMID: 36261811 Free PMC article.
[Myocardial injury in coronavirus disease 19 (Covid-19): main pathophysiological mechanisms and clinical utility of cardiac biomarkers].
Kamel S, Raynor A, Zozor S, Lacape G, Brunel V, Nivet-Antoine V, Collin-Chavagnac D, Peoc'h K, Cohen A, Lassoued AB, Chévrier M, Alemann M, Lessinger JM, Bérard AM, Sapin V, Beauvieux MC, Levy P; Pour le Groupe de Travail de la SFBC « Marqueurs Biochimiques de la pathologie Covid-19 ». Kamel S, et al. Among authors: lessinger jm. Ann Biol Clin (Paris). 2021 Jun 1;79(3):219-231. doi: 10.1684/abc.2021.1642. Ann Biol Clin (Paris). 2021. PMID: 34165431 Free article. French.
COVID-19 exposure in SARS-CoV-2-seropositive hospital staff members during the first pandemic wave at Strasbourg University Hospital, France.
Velay A, Gallais F, Wendling MJ, Bayer S, Reix N, Schneider A, Glady L, Collongues N, Lessinger JM, Hansmann Y, Kling-Pillitteri L, De Sèze J, Gonzalez M, Schmidt-Mutter C, Meyer N, Fafi-Kremer S. Velay A, et al. Among authors: lessinger jm. Infect Dis Now. 2022 Feb;52(1):23-30. doi: 10.1016/j.idnow.2021.11.002. Epub 2021 Nov 11. Infect Dis Now. 2022. PMID: 34775140 Free PMC article.
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection.
Gallais F, Gantner P, Bruel T, Velay A, Planas D, Wendling MJ, Bayer S, Solis M, Laugel E, Reix N, Schneider A, Glady L, Panaget B, Collongues N, Partisani M, Lessinger JM, Fontanet A, Rey D, Hansmann Y, Kling-Pillitteri L, Schwartz O, De Sèze J, Meyer N, Gonzalez M, Schmidt-Mutter C, Fafi-Kremer S. Gallais F, et al. Among authors: lessinger jm. EBioMedicine. 2021 Sep;71:103561. doi: 10.1016/j.ebiom.2021.103561. Epub 2021 Aug 27. EBioMedicine. 2021. PMID: 34455390 Free PMC article.
An Innovative Fluorescent Semi-quantitative Methylation-specific PCR Method for the Determination of MGMT Promoter Methylation is Reflecting Intra-tumor Heterogeneity.
Nguyen A, Legrain M, Noel G, Coca A, Meyer Ea N, Schott R, Lasthaus C, Chenard MP, Gaub MP, Lessinger JM, Guenot D, Entz-Werle N. Nguyen A, et al. Among authors: lessinger jm. Curr Cancer Drug Targets. 2015;15(7):624-40. doi: 10.2174/1568009615666150629130139. Curr Cancer Drug Targets. 2015. PMID: 26118907
75 results